Comprehensive Study Guide: Speak Out, Loud Crowd, and Forte Therapy Models

Article 1: Hybrid Speak Out Treatments

  • Study Design: This was a quasi-experimental study design focusing on hybrid Speak Out treatments.

  • Participant Demographics:

    • Total participants: 157.

    • Diagnosis: Individuals with Parkinson’s disease and secondary hypokinetic dysarthria.

  • Treatment Targets: The primary focus was on "speaking with intent" approaches.

  • Clinical Outcomes and Measures:

    • Observed increases in maximum phonation time (MPTMPT).

    • Improvements in peak expiratory flow (PEFPEF) and peak cough flow (PCFPCF).

    • Improvements in Patient-Reported Outcome Measure (PROMPROM) scores.

    • The results supported the treatment's effectiveness in improving function, activity levels, and overall participation.

Article 2: Telehealth and Functional Speech Measures

  • Study Design: An experimental study focusing on the effects of Speak Out and Loud Crowd on functional speech measures in Parkinson’s disease.

  • Participant Demographics: Six adult patients with hypokinetic dysarthria secondary to Parkinson’s disease.

  • Methodology:

    • All six participants underwent Speak Out and Loud Crowd therapy.

    • Notably, the majority of sessions were conducted via telehealth rather than in-person.

  • Findings:

    • The study supported the effectiveness of these treatment programs for improving communication participation and communication skills.

    • The positive effects noted in telehealth sessions suggest it is a viable alternative to in-person promotion, which is less commonly discussed in literature.

Article 3: In-Person Speak Out and Loud Crowd Parameters

  • Study Design: An experimental study involving 40 participants with hypokinetic dysarthria resulting from Parkinson’s disease.

  • Treatment Dosage and Setting:

    • All sessions were conducted in person.

    • Speak Out: 12 individual sessions, conducted three times per week over the course of four weeks (12sessions×3weeks1×4weeks12\,sessions \times 3\,weeks^{-1} \times 4\,weeks).

    • Loud Crowd: Group sessions conducted one time per week (1sessionweek11\,session\,week^{-1}).

  • Clinical Measures:

    • Increasing prosody.

    • Increasing Cepstral Peak Prominence (CPPCPP) or steep shoulder prominence.

    • Increase in the Voice-Related Quality of Life (VRQOLV-RQOL) measure, which is a patient-reported outcome (PROPRO).

  • Outcome: The treatment was found effective across all measured areas following post-treatment assessment.

Theoretical Framework for Parkinson’s Speech Therapy

  • Treatment Targets: Improving vocal loudness, vocal quality, speech intelligibility, speaking rate, and overall respiratory rate.

  • Key Ingredients:

    • Pitch glides and sustained phonation (e.g.,e.g., sustained vowels).

    • Breathing exercises.

    • Producing sentences (reading or conversational).

    • Reading oral passages (moving from sustained vowels to connected speech).

    • External cueing provided by clinicians to redirect the patient toward clear, purposeful speech.

  • Mechanism of Action:

    • Focuses on the muscles of the larynx responsible for the coordination of phonation.

    • Overcoming impaired neural pathways in the basal ganglia and thalamus that manage habitual/automatic speech.

    • By using intentional speech, patients bypass automatic motor deficits.

  • Volition Targets:

    • Speaking with intent and speaking loudly.

    • Breath control.

    • Directing cognitive effort volitionally toward speech production.

  • General Dosage Parameters (Consolidated):

    • Speak Out: Typically three to four sessions per week (34sessionsweek13-4\,sessions\,week^{-1}), lasting 4550minutes45-50\,minutes each, for a duration of four to eight weeks.

    • Loud Crowd: Typically one group session per week (1sessionweek11\,session\,week^{-1}) for maintenance.

Therapeutic Interpretation and Considerations

  • Pathology Context: In Parkinson’s disease, internal cues for speech intensity and loudness originate in the basal ganglia and thalamus. Because these are impaired, patients have an altered perception of their own loudness (autonomic function failure).

  • Structural Variations: Treatment responses differ because every patient has unique anatomy, structural/functional limitations, and a range of severity/symptom progression.

  • Cognitive and Salience Factors: Therapy materials (like those in the Speak Out book) must provide salience to the patient to ensure motivation and participation.

  • Limitations of Treatment:

    • Improvement in aerodynamic measures (like MPTMPT or intensity) does not always guarantee improved functional communication.

    • Improvement in a patient's perception of their quality of life might occur even if objective measures (like CPPCPP) do not show significant change.

    • Success is not guaranteed across all three domains (aerodynamics, communication, and perception) simultaneously.

Demonstration: Speak Out and Loud Crowd Components

  • Component 1: Sustained Phonation: Producing a sustained "ah" (ah\text{ah}) with intent. The patient is cued to "speak as if talking to the wall behind the clinician."

  • Component 2: Numerical Sequences: Counting (e.g., 1 to 12) with purposeful pauses every three to five numbers (1,2,34,5,61, 2, 3 \dots 4, 5, 6 \dots) to help with speaking rate and percent pause time.

  • Component 3: Connected Speech: Reading passages or sentences (e.g.,e.g., "I am a graduate student of speech pathology at East Tennessee State University").

  • Component 4: Cognitive-Linguistic Exercises (Loud Crowd): Engaging in group conversation about daily life (e.g.,e.g., weekend plans) while maintaining intent. This requires word-finding skills and creating novel responses while managing posture and loudness.

  • Omitted Components in Demo: Nasal phoneme warm-ups and pitch glides.

Forte and Expiratory Muscle Strength Training (EMST)

  • EMST Targets and Mechanism:

    • Target: Maximum Expiratory Pressure (MEPMEP).

    • Mechanism: Increasing the strength of thoracic, intercostal, and abdominal muscles to generate forceful exhalation.

    • Outcome goal: Decrease the demand on vocal folds to prevent phonotrauma or overcompensation.

  • Forte Protocol:

    • Targets: Acoustic qualities, vocal quality, loudness, and decreasing vocal effort.

    • Population: Often used for presbyphonia (age-related voice changes, such as breathiness or atrophy).

    • Ingredients: High-intensity and low-intensity functional phrases, pitch glides (ah,ah\text{ah} \uparrow, \text{ah} \downarrow), and sustained phonation.

  • Dosage: Patients are often tasked with home exercises five times per day, five sets each (5sets×5timesday15\,sets \times 5\,times\,day^{-1}), six times per week.

Case Studies in Presbyphonia

  • Case 1 (Single Subject): Participants met for a four-week timeframe. Intervention included IMST/EMST set at 75%75\% intensity. Findings showed improvement in vocal intensity and respiratory strength based on the Voice Handicap Index (VHIVHI).

  • Case 2 (Forte vs. Forte + EMST):

    • Participants: Originally 26, 16 completed (n=16n=16). All aged >55 (average age 73.5years73.5\,years).

    • Groups: Forte only vs. Forte + EMST (70%70\% resistance).

    • Results:

      • Vocal intensity increased in both: Forte only increased by 4dB4\,dB; Forte + EMST increased by 68dB6-8\,dB.

      • MEPMEP significantly increased in the combination group (Forte+EMSTForte + EMST).

      • Normal MEPMEP for females is roughly 80cmH2O80\,cm\,H_2O and for males 100cmH2O100\,cm\,H_2O. Participants started below these levels.

  • Case 3 (VFE vs. VFE + Strength Training):

    • Groups: Vocal Function Exercises (VFEVFE), VFE+IMSTVFE + IMST, and VFE+EMSTVFE + EMST.

    • Highest satisfaction and carryover was found in the VFE+IMSTVFE + IMST group due to combined vocal quality and respiratory support focus.

Questions & Discussion

  • Q: Which program is individualized and which is group-focused?

    • A: Speak Out is primarily individualized (one patient, one clinician). Loud Crowd is group-focused therapy (maintenance and practice).

  • Q: What is hypokinetic dysarthria?

    • A: It is a speech disorder characterized by a slower rate of speaking (hypo- meaning less/low), tremors, and muscle weakness common in Parkinson’s, making speech difficult to understand and execute at a normal rate.

  • Q: Is Loud Crowd done in public (like a coffee shop)?

    • A: While it involves groups, the research observed it in controlled clinic environments rather than noisy public spaces.

  • Q: Why does sitting upright help if intensity is the only target?

    • A: Posture changes the anatomical features. Sitting upright decreases pressure on the chest and opens the airway, facilitating better airflow and laryngeal adjustment, which allows for louder phonation without straining.

  • Q: Is Speak Out training available?

    • A: Training for Speak Out is currently free. Additionally, the term "Loud Crowd" is being phased out in favor of the name "Speak Out Group Therapy."

  • Q: How do you identify presbyphonia specifically?

    • A: Diagnosis involves acoustic and perceptual analysis. Characteristics include a weakened voice, thinning of the vocal folds (atrophy), and maximum expiratory pressures falling below normal ranges.

  • Q: What was the role of the mobile app mentioned in the research?

    • A: It was used to track vocal intensity at home. Participants had to hold the phone exactly 12cm12\,cm from their face in a room with no background noise. Due to these strict requirements and lifestyle conflicts, only 20%20\% of participants used it reliably.